Docteur PHILIPPE RAVAUD
Diplômes
🎓 DES & spécialité ordinale
- Rhumatologie (SM)
🎓 Diplômes
- DE Docteur en médecine
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Thèses universitaires
Source : catalogue national des thèses theses.fr (ABES). Ne couvre que les doctorats / HDR — les thèses d'exercice (DES) sont archivées dans les SCD universitaires.
Direction de thèses
🎓 6 thèses dirigéesLe gaspillage évitable de la recherche dans les essais cliniques
2019Doctorant·e : Youri Yordanov
Santé publique. Epidémiologie et science de l'information🎓 Sorbonne Paris CitéEvaluation de la recherche post AMM et de ses déterminations
2018Doctorant·e : Jean david Zeitoun
Epidemiologie🎓 Sorbonne Paris CitéEvaluation de la contribution des maladies musculosquelettiques au handicap en France à partir de l'enquête Handicap-santé
2016Doctorant·e : Clémence Cambon-Palazzo
Santé publique, Epidémiologie, Sciences de l'information biomédicale🎓 Sorbonne Paris CitéL'hémorragie du post-partum immédiat sévère : étude des variations de pratique de prise en charge. Analyse des déterminants organisationnels et personnels
2016Doctorant·e : Anne Rousseau
Santé publique, Epidémiologie et Science de l'information biomédicale🎓 Sorbonne Paris CitéÉpidémiologie et méthodologie des méta-analyses en réseau
2015Doctorant·e : Aïda Bafeta
Santé Publique. Epidémiologie et Sciences de l'Information Biomédicale🎓 Sorbonne Paris CitéDéveloppement d'outils de mesure du fardeau du traitement chez des patients souffrant de plusieurs maladies chroniques
2015Doctorant·e : Viet-Thi Tran
Santé Publique. Epidémiologie et Sciences de l'Information Biomédicale🎓 Sorbonne Paris Cité
Source theses.fr — signal de direction d'équipe / statut PU-PH (à confirmer via le site universitaire).
Activité de recherche & publications
Source : bases de données publiques (OpenAlex, PubMed).
h-index
131
h articles cités ≥ h fois chacun. Un h de 131 = 131 publications avec 131+ citations.
Citations
58 716
Publications
1026
i10-index
513
Thématiques principales
- Meta-analysis and systematic reviews ×199
- Rheumatoid Arthritis Research and Therapies ×126
- Health Systems, Economic Evaluations, Quality of Life ×102
- Ethics in Clinical Research ×67
- Statistical Methods in Clinical Trials ×60
Affiliations FR : Délégation Paris 5 · Inserm · Inserm
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Bibliographie
Levels of circulating kidney injury markers and IL-10 identify non-critically ill patients with COVID-19 at risk of death
2026ArticleJCI Insight
Methods and reporting of studies assessing the impact of adherence to clinical practice guidelines: a scoping review
2025ArticleBMC Medicine
A Consensus Statement on establishing causality, therapeutic applications and the use of preclinical models in microbiome research
2025ArticleNature reviews. Gastroenterology & hepatology
A scoping review of robustness concepts for machine learning in healthcare
2025Articlenpj Digital Medicine
AMI-Sleep: protocol for a prospective study of sleep-disordered breathing/sleep apnoea syndrome and incident cardiovascular events after acute myocardial infarction
2025ArticleBMJ Open
Microbiome testing in Europe: navigating analytical, ethical and regulatory challenges
2024ArticleMicrobiome
Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort
2024ArticleRheumatology
Algorithmovigilance, lessons from pharmacovigilance
2024Articlenpj Digital Medicine
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Lieu de consultation
GHU APHP CUP SITE HOTEL DIEU
1 Place DU PARVIS DE NOTRE DAME, 75181 Paris 4e Arrondissement
☎ 0142348234Hospitalier
Tarifs & secteur de conventionnement
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Top publications · les plus citées
- 1CONSORT 2025 statement: updated guideline for reporting randomised trials
BMJ (Clinical research ed.) · 2025
Lire l'abstract Crossref ↓
Abstract Background Well designed and properly executed randomised trials are considered the most reliable evidence on the benefits of healthcare interventions. However, there is overwhelming evidence that the quality of reporting is not optimal. The CONSORT (Consolidated Standards of Reporting Trials) statement was designed to improve the quality of reporting and provides a minimum set of items to be included in a report of a randomised trial. CONSORT was first published in 1996, then updated in 2001 and 2010. Here, we present the updated CONSORT 2025 statement, which aims to account for recent methodological advancements and feedback from end users. Methods We conducted a scoping review of the literature and developed a project-specific database of empirical and theoretical evidence related to CONSORT, to generate a list of potential changes to the checklist. The list was enriched with recommendations provided by the lead authors of existing CONSORT extensions (Harms, Outcomes, Non-pharmacological Treatment), other related reporting guidelines (TIDieR) and recommendations from other sources (eg, personal communications). The list of potential changes to the checklist was assessed in a large, international, online, three-round Delphi survey involving 317 participants and discussed at a two-day online expert consensus meeting of 30 invited international experts. Results We have made substantive changes to the CONSORT checklist. We added seven new checklist items, revised three items, deleted one item, and integrated several items from key CONSORT extensions. We also restructured the CONSORT checklist, with a new section on open science. The CONSORT 2025 statement consists of a 30-item checklist of essential items that should be included when reporting the results of a randomised trial and a diagram for documenting the flow of participants through the trial. To facilitate implementation of CONSORT 2025, we have also developed an expanded version of the CONSORT 2025 checklist, with bullet points eliciting critical elements of each item. Conclusion Authors, editors, reviewers, and other potential users should use CONSORT 2025 when writing and evaluating manuscripts of randomised trials to ensure that trial reports are clear and transparent.
- 2SPIRIT 2025 statement: updated guideline for protocols of randomised trials
BMJ (Clinical research ed.) · 2025
Lire l'abstract Crossref ↓
Abstract Importance The protocol of a randomised trial is the foundation for study planning, conduct, reporting, and external review. However, trial protocols vary in their completeness and often do not address key elements of design and conduct. The SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) statement was first published in 2013 as guidance to improve the completeness of trial protocols. Periodic updates incorporating the latest evidence and best practices are needed to ensure that the guidance remains relevant to users. Objective To systematically update the SPIRIT recommendations for minimum items to address in the protocol of a randomised trial. Design We completed a scoping review and developed a project specific database of empirical and theoretical evidence to generate a list of potential changes to the SPIRIT 2013 checklist. The list was enriched with recommendations provided by lead authors of existing SPIRIT/CONSORT (Consolidated Standards of Reporting Trials) extensions (Harms, Outcomes, Non-pharmacological Treatment) and other reporting guidelines (TIDieR). The potential modifications were rated in a three-round Delphi survey followed by a consensus meeting. Findings Overall, 317 individuals participated in the Delphi consensus process and 30 experts attended the consensus meeting. The process led to the addition of two new protocol items, revision to five items, deletion/merger of five items, and integration of key items from other relevant reporting guidelines. Notable changes include a new open science section, additional emphasis on the assessment of harms and description of interventions and comparators, and a new item on how patients and the public will be involved in trial design, conduct, and reporting. The updated SPIRIT 2025 statement consists of an evidence based checklist of 34 minimum items to address in a trial protocol, along with a diagram illustrating the schedule of enrolment, interventions, and assessments for trial participants. To facilitate implementation, we also developed an expanded version of the SPIRIT 2025 checklist and an accompanying explanation and elaboration document. Conclusions and relevance Widespread endorsement and adherence to the updated SPIRIT 2025 statement have the potential to enhance the transparency and completeness of trial protocols for the benefit of investigators, trial participants, patients, funders, research ethics committees, journals, trial registries, policymakers, regulators, and other reviewers.
- 3CONSORT 2025 statement: updated guideline for reporting randomised trials
Lancet (London, England) · 2025
📚 193 citations🎯 RCR 91.63🔓 Open Access
Publications scientifiques (50) — classées par pathologie
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Essai clinique18
▼
Essai clinique18
▼- Using large language models to directly screen electronic databases as an alternative to traditional search strategies such as the Cochrane highly sensitive search for filtering randomized controlled trials in systematic reviews
Research synthesis methods · 2025 · Journal Article
Tran VT, Grana Possamai C, Boutron I, Ravaud P
- SPIRIT 2025 Statement: Updated Guideline for Protocols of Randomized Trials
JAMA · 2025 · Journal Article
Chan AW, Boutron I, Hopewell S, Moher D, et al.
📚 48 cit.🎯 RCR 22.54🩺 Clinique - CONSORT 2025 statement: updated guideline for reporting randomized trials: a Korean translation
Ewha medical journal · 2025 · Guideline
Hopewell S, Chan AW, Collins GS, Hróbjartsson A, et al.
📚 4 cit.🩺 Clinique - Do peer reviewers comment on reporting items as instructed by the journal? A secondary analysis of two randomized trials
Journal of clinical epidemiology · 2025 · Journal Article
Wnfried Ramirez H, Chiaborelli M, Schönenberger CM, Mellor K, et al.
📚 1 cit. - CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials
JAMA · 2025 · Guideline
Hopewell S, Chan AW, Collins GS, Hróbjartsson A, et al.
📚 142 cit.🎯 RCR 63.38🩺 Clinique - SPIRIT 2025 statement: updated guideline for protocols of randomized trials
Nature medicine · 2025 · Journal Article
Chan AW, Boutron I, Hopewell S, Moher D, et al.
📚 55 cit.🎯 RCR 25.36🔬→🩺 Translationnel - CONSORT 2025 statement: updated guideline for reporting randomized trials
Nature medicine · 2025 · Journal Article
Hopewell S, Chan AW, Collins GS, Hróbjartsson A, et al.
📚 112 cit.🎯 RCR 53.79🔬→🩺 Translationnel - SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials
BMJ (Clinical research ed.) · 2025 · Journal Article
Hróbjartsson A, Boutron I, Hopewell S, Moher D, et al.
📚 67 cit.🎯 RCR 31.14🔬→🩺 Translationnel - SPIRIT 2025 statement: updated guideline for protocols of randomised trials
BMJ (Clinical research ed.) · 2025 · Consensus Statement
Chan AW, Boutron I, Hopewell S, Moher D, et al.
📚 201 cit.🎯 RCR 92.59🔬→🩺 Translationnel - SPIRIT 2025 statement: Updated guideline for protocols of randomised trials
PLoS medicine · 2025 · Consensus Statement
Chan AW, Boutron I, Hopewell S, Moher D, et al.
📚 33 cit.🎯 RCR 15.37🔬→🩺 Translationnel - CONSORT 2025 statement: updated guideline for reporting randomised trials
Lancet (London, England) · 2025 · Journal Article
Hopewell S, Chan AW, Collins GS, Hróbjartsson A, et al.
📚 193 cit.🎯 RCR 91.63🔬→🩺 Translationnel - CONSORT 2025 statement: updated guideline for reporting randomised trials
BMJ (Clinical research ed.) · 2025 · Journal Article
Hopewell S, Chan AW, Collins GS, Hróbjartsson A, et al.
📚 598 cit.🎯 RCR 285.06🔬→🩺 Translationnel - CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials
BMJ (Clinical research ed.) · 2025 · Journal Article
Hopewell S, Chan AW, Collins GS, Hróbjartsson A, et al.
📚 119 cit.🎯 RCR 57.82🔬→🩺 Translationnel - CONSORT 2025 statement: Updated guideline for reporting randomised trials
PLoS medicine · 2025 · Journal Article
Hopewell S, Chan AW, Collins GS, Hróbjartsson A, et al.
📚 45 cit.🎯 RCR 21.43🔬→🩺 Translationnel - Development of ROBUST-RCT: Risk Of Bias instrument for Use in SysTematic reviews-for Randomised Controlled Trials
BMJ (Clinical research ed.) · 2025 · Journal Article
Wang Y, Keitz S, Briel M, Glasziou P, et al.
📚 14 cit.🎯 RCR 6.56 - Characteristics of non-randomised studies of drug treatments: cross sectional study
BMJ medicine · 2024 · Journal Article
Yaacoub S, Porcher R, Pellat A, Bonnet H, et al.
📚 8 cit.🎯 RCR 1.56 - Compelling evidence from meta-epidemiological studies demonstrates overestimation of effects in randomized trials that fail to optimize randomization and blind patients and outcome assessors
Journal of clinical epidemiology · 2024 · Journal Article
Wang Y, Parpia S, Couban R, Wang Q, et al.
📚 35 cit.🎯 RCR 9.60🔬→🩺 Translationnel - Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial
BMJ medicine · 2023 · Journal Article
Lacombe K, Hueso T, Porcher R, Mekinian A, et al.
📚 18 cit.🎯 RCR 1.46🔬→🩺 Translationnel
Transversal18
▼
Transversal18
▼- Practical elements to consider when emulating a target trial
Journal of clinical epidemiology · 2026 · Journal Article
Tran VT, Porcher R, Perrodeau E, Yaacoub S, et al.
- Patient Preferences for In-Person vs Remote Care for Long-Term Conditions
JAMA network open · 2026 · Journal Article
Lenfant T, Perrodeau E, Ravaud P, Tran VT
📚 1 cit. - Including nonrandomized evidence in living systematic reviews: lessons learned from the COVID-NMA initiative
Journal of clinical epidemiology · 2026 · Journal Article
Bonnet H, Higgins JPT, Chaimani A, Evrenoglou T, et al.
- Levels of circulating kidney injury markers and IL-10 identify non-critically ill patients with COVID-19 at risk of death
JCI insight · 2026 · Journal Article
Lenoir O, Morin F, Walter-Petrich A, Resmini L, et al.
🩺 Clinique - Integrating personomics into precision medicine
Journal of clinical epidemiology · 2025 · Journal Article
Krause KR, Ravaud P, Tran VT
- Discordances in patients' and physicians' perspectives on which contextual factors should be accounted for during smoking cessation
Family practice · 2024 · Journal Article
Malmartel A, Ravaud P, Tran VT
- Algorithmovigilance, lessons from pharmacovigilance
NPJ digital medicine · 2024 · Journal Article
Balendran A, Benchoufi M, Evgeniou T, Ravaud P
📚 8 cit.🎯 RCR 1.69 - Preferred study designs to support a comparative therapeutic strategy question in oncology: a vignette study
Journal of clinical epidemiology · 2024 · Journal Article
Pellat A, Boutron I, Perrodeau E, Porcher R, et al.
- Identifying psychosocial and contextual markers considered by physicians to personalize care
BMC medicine · 2024 · Journal Article
Domenach P, Krause KR, Malmartel A, Ravaud P, et al.
📚 1 cit. - Reporting on data sharing: executive position of the EQUATOR Network
BMJ (Clinical research ed.) · 2024 · Journal Article
Moher D, Collins G, Hoffmann T, Glasziou P, et al.
📚 21 cit.🎯 RCR 5.44🔬→🩺 Translationnel - Rationale and design of the FRENch CoHort of myocardial Infarction Evaluation (FRENCHIE) study
Archives of cardiovascular diseases · 2024 · Journal Article
Gautier A, Danchin N, Ducrocq G, Rousseau A, et al.
📚 5 cit.🎯 RCR 1.26🩺 Clinique - A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials
The British journal of dermatology · 2024 · Systematic Review
Fertitta L, Bergqvist C, Sarin KY, Plotkin SR, et al.
📚 5 cit.🎯 RCR 1.83 - Risk factors for thromboembolic events in patients hospitalized for COVID-19 pneumonia in a general ward and requiring treatment with oxygen
Postgraduate medical journal · 2024 · Randomized Controlled Trial
Degrave R, Murris J, Charles-Nelson A, Hermine O, et al.
🩺 Clinique - Five principles for the development of minimally disruptive digital medicine
BMJ (Clinical research ed.) · 2023 · Editorial
Lenfant T, Ravaud P, Montori VM, Berntsen GR, et al.
📚 11 cit.🎯 RCR 1.77 - More rapid blood interferon α2 decline in fatal versus surviving COVID-19 patients
Frontiers in immunology · 2023 · Journal Article
Joly C, Desjardins D, Porcher R, Péré H, et al.
📚 3 cit.🔬→🩺 Translationnel - cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States Adults
The Journal of investigative dermatology · 2023 · Journal Article
Fertitta L, Sarin KY, Bergqvist C, Patel E, et al.
📚 2 cit. - Trajectories of the evolution of post-COVID-19 condition, up to two years after symptoms onset
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023 · Journal Article
Servier C, Porcher R, Pane I, Ravaud P, et al.
📚 35 cit.🎯 RCR 4.76🔬→🩺 Translationnel - A methodological framework allows the identification of personomic markers to consider when designing personalized interventions
Journal of clinical epidemiology · 2023 · Journal Article
Malmartel A, Ravaud P, Tran VT
📚 6 cit.🎯 RCR 1.01
Recommandations12
▼
Recommandations12
▼- SPIRIT 2025 Statement: Updated Guideline for Protocols of Randomized Trials
JAMA · 2025 · Journal Article
Chan AW, Boutron I, Hopewell S, Moher D, et al.
📚 48 cit.🎯 RCR 22.54🩺 Clinique - CONSORT 2025 statement: updated guideline for reporting randomized trials: a Korean translation
Ewha medical journal · 2025 · Guideline
Hopewell S, Chan AW, Collins GS, Hróbjartsson A, et al.
📚 4 cit.🩺 Clinique - CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials
JAMA · 2025 · Guideline
Hopewell S, Chan AW, Collins GS, Hróbjartsson A, et al.
📚 142 cit.🎯 RCR 63.38🩺 Clinique - SPIRIT 2025 statement: updated guideline for protocols of randomized trials
Nature medicine · 2025 · Journal Article
Chan AW, Boutron I, Hopewell S, Moher D, et al.
📚 55 cit.🎯 RCR 25.36🔬→🩺 Translationnel - CONSORT 2025 statement: updated guideline for reporting randomized trials
Nature medicine · 2025 · Journal Article
Hopewell S, Chan AW, Collins GS, Hróbjartsson A, et al.
📚 112 cit.🎯 RCR 53.79🔬→🩺 Translationnel - SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials
BMJ (Clinical research ed.) · 2025 · Journal Article
Hróbjartsson A, Boutron I, Hopewell S, Moher D, et al.
📚 67 cit.🎯 RCR 31.14🔬→🩺 Translationnel - SPIRIT 2025 statement: updated guideline for protocols of randomised trials
BMJ (Clinical research ed.) · 2025 · Consensus Statement
Chan AW, Boutron I, Hopewell S, Moher D, et al.
📚 201 cit.🎯 RCR 92.59🔬→🩺 Translationnel - SPIRIT 2025 statement: Updated guideline for protocols of randomised trials
PLoS medicine · 2025 · Consensus Statement
Chan AW, Boutron I, Hopewell S, Moher D, et al.
📚 33 cit.🎯 RCR 15.37🔬→🩺 Translationnel - CONSORT 2025 statement: updated guideline for reporting randomised trials
Lancet (London, England) · 2025 · Journal Article
Hopewell S, Chan AW, Collins GS, Hróbjartsson A, et al.
📚 193 cit.🎯 RCR 91.63🔬→🩺 Translationnel - CONSORT 2025 statement: updated guideline for reporting randomised trials
BMJ (Clinical research ed.) · 2025 · Journal Article
Hopewell S, Chan AW, Collins GS, Hróbjartsson A, et al.
📚 598 cit.🎯 RCR 285.06🔬→🩺 Translationnel - CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials
BMJ (Clinical research ed.) · 2025 · Journal Article
Hopewell S, Chan AW, Collins GS, Hróbjartsson A, et al.
📚 119 cit.🎯 RCR 57.82🔬→🩺 Translationnel - CONSORT 2025 statement: Updated guideline for reporting randomised trials
PLoS medicine · 2025 · Journal Article
Hopewell S, Chan AW, Collins GS, Hróbjartsson A, et al.
📚 45 cit.🎯 RCR 21.43🔬→🩺 Translationnel
Revue générale6
▼
Revue générale6
▼- A scoping review of ICHOM Sets identifies a small number of commonly recommended baseline characteristics
Journal of clinical epidemiology · 2026 · Journal Article
Salman M, Tran VT, Boutron I, Ravaud P, et al.
- Methods and reporting of studies assessing the impact of adherence to clinical practice guidelines: a scoping review
BMC medicine · 2025 · Journal Article
Yazbeck B, Boutron I, Porcher R, Riveros C, et al.
📚 2 cit. - Inclusion of Retracted Studies in Systematic Reviews and Meta-Analyses of Interventions: A Systematic Review and Meta-Analysis
JAMA internal medicine · 2025 · Journal Article
Graña Possamai C, Cabanac G, Perrodeau E, Ghosn L, et al.
📚 12 cit.🎯 RCR 5.34 - Cumulative Burden of Digital Health Technologies for Patients With Multimorbidity: A Systematic Review
JAMA network open · 2025 · Journal Article
Phi NTT, Montori VM, Kunneman M, Ravaud P, et al.
📚 8 cit.🎯 RCR 3.93 - Mapping the Evidence Supporting Digital Therapeutics: A Review
JAMA internal medicine · 2024 · Journal Article
Amyx M, Phi NTT, Alebouyeh F, Ravaud P, et al.
📚 3 cit. - Assessment of US Food and Drug Administration-Approved Digital Medical Devices for Just-in-Time Interventions: A Systematic Review
JAMA internal medicine · 2023 · Journal Article
Phi NTT, Oikonomidi T, Ravaud P, Tran VT
📚 6 cit.
Revue / méta-analyse4
▼
Revue / méta-analyse4
▼- Using large language models to directly screen electronic databases as an alternative to traditional search strategies such as the Cochrane highly sensitive search for filtering randomized controlled trials in systematic reviews
Research synthesis methods · 2025 · Journal Article
Tran VT, Grana Possamai C, Boutron I, Ravaud P
- Inclusion of Retracted Studies in Systematic Reviews and Meta-Analyses of Interventions: A Systematic Review and Meta-Analysis
JAMA internal medicine · 2025 · Journal Article
Graña Possamai C, Cabanac G, Perrodeau E, Ghosn L, et al.
📚 12 cit.🎯 RCR 5.34 - Cumulative Burden of Digital Health Technologies for Patients With Multimorbidity: A Systematic Review
JAMA network open · 2025 · Journal Article
Phi NTT, Montori VM, Kunneman M, Ravaud P, et al.
📚 8 cit.🎯 RCR 3.93 - Assessment of US Food and Drug Administration-Approved Digital Medical Devices for Just-in-Time Interventions: A Systematic Review
JAMA internal medicine · 2023 · Journal Article
Phi NTT, Oikonomidi T, Ravaud P, Tran VT
📚 6 cit.
IA en rhumatologie3
▼
IA en rhumatologie3
▼- Real-world validation of a multimodal LLM-powered pipeline for high-accuracy clinical trial patient matching
Communications medicine · 2025 · Journal Article
Callies A, Bodinier Q, Ravaud P, Davarpanah K
- A scoping review of robustness concepts for machine learning in healthcare
NPJ digital medicine · 2025 · Journal Article
Balendran A, Beji C, Bouvier F, Khalifa O, et al.
📚 12 cit.🎯 RCR 4.56 - Sensitivity and Specificity of Using GPT-3.5 Turbo Models for Title and Abstract Screening in Systematic Reviews and Meta-analyses
Annals of internal medicine · 2024 · Journal Article
Tran VT, Gartlehner G, Yaacoub S, Boutron I, et al.
📚 36 cit.🎯 RCR 11.97
Anti-TNF1
▼
Anti-TNF1
▼- Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort
Rheumatology (Oxford, England) · 2025 · Journal Article
Nguyen Y, Baron G, Hamamouche N, Belkhir R, et al.
📚 1 cit.🩺 Clinique
Biothérapies non-anti-TNF1
▼
Biothérapies non-anti-TNF1
▼- Can efficacy and safety data from clinical trials of rituximab in RA be extrapolated? Insights from 1984 patients from the AIR-PR Registry
Rheumatology (Oxford, England) · 2024 · Journal Article
Nguyen Y, Mariette X, Gottenberg JE, Iudici M, et al.
📚 2 cit.
Économie santé1
▼
Économie santé1
▼- Cumulative Burden of Digital Health Technologies for Patients With Multimorbidity: A Systematic Review
JAMA network open · 2025 · Journal Article
Phi NTT, Montori VM, Kunneman M, Ravaud P, et al.
📚 8 cit.🎯 RCR 3.93
Qualité de vie / PROMs1
▼
Qualité de vie / PROMs1
▼- Psychometric properties and domains covered by patient-reported outcome measures used in trials assessing interventions for chronic pain
Journal of clinical epidemiology · 2024 · Journal Article
Alebouyeh F, Boutron I, Ravaud P, Tran VT
📚 3 cit.🎯 RCR 1.02🔬→🩺 Translationnel
Santé mentale / fatigue1
▼
Santé mentale / fatigue1
▼- AMI-Sleep: protocol for a prospective study of sleep-disordered breathing/sleep apnoea syndrome and incident cardiovascular events after acute myocardial infarction
BMJ open · 2025 · Journal Article
Balagny P, D'Ortho MP, Berard L, Rousseau A, et al.
Vraie vie / RWE1
▼
Vraie vie / RWE1
▼- Accelerating real-world prediction and research in Alzheimer's: The M3AD study
Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026 · Journal Article
Desvarieux M, Rundek T, Ahsan H, Narvaez J, et al.
Datasets & protocoles partagés
Reporting studies on time to diagnosis: proposal of a guideline by an international panel (REST)
Collection2016figshareAbstract Background Studies on time to diagnosis are an increasing field of clinical research that may help to plan corrective actions and identify inequities in access to healthcare. Specific features of time to diagnos
Additional file 2: of Automatic classification of registered clinical trials towards the Global Burden of Diseases taxonomy of diseases and injuries
Dataset2016FigshareClassification towards the 28-class grouping of GBD categories of all interventional trials registered at WHO ICTRP before February 2014. Classification of N = 109,603 clinical trials using the best-performing version of
Development and Evaluation of a Pedagogical Tool to Improve Understanding of a Quality Checklist: A Randomised Controlled Trial-0
Image2011figshare<b>Copyright information:</b>Taken from "Development and Evaluation of a Pedagogical Tool to Improve Understanding of a Quality Checklist: A Randomised Controlled Trial"PLoS Clinical Trials 2007;2(5):-.Published online 4
Protocol for a systematic review of N-of-1 trial protocol guidelines and protocol reporting guidelines
Collection2017figshareAbstract Background N-of-1 trials are multiple cross-over trials done in individual participants, generating individual treatment effect information. While reporting guidelines for the CONSORT Extension for N-of-1 trials
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).
